The role of temperature in the action of local anesthetics was studied in 20 healthy young volunteers with plain 3% mepivacaine injected periapically twice in their maxillary first premolar, the first time with the solution at a temperature of 20ЊC and the second time at 4ЊC. The pulpal response was measured with a pulp tester every minute. The onset of pulp anesthesia was found to be of no statistical difference between 20ЊC and 4ЊC. On the other hand, mepivacaine at a temperature of 4ЊC was found to have a statistically significant longer duration of action. Our conclusion is that the drop in temperature of mepivacaine from 20ЊC to 4ЊC provides a longer duration of pulpal anesthesia.Key Words: Temperature; Mepivacaine; Local anesthesia; Mechanism of action, onset, duration.
It is well known since ancient times that the placement of something cold (eg, ice) produces anesthesia at the specific site of its placement.1 Moreover, the effect of lidocaine in blocking nerve impulses both in vitro and in vivo is potentiated by cooling.2-4 The nerve-blocking effect of lidocaine is also reported as being potentiated by increasing the temperature above 37ЊC.2 In other studies, the potency of various tertiary amine local anesthetics in impairing the excitability of frog skeletal muscle was markedly enhanced by an increase in temperature from 20ЊC to 30ЊC, and enhancement of the local anesthetic effects was also produced by a decrease in temperature to 5ЊC.5 Temperature may thus be an interesting physical variable in the study of nerve-blocking mechanisms. Given the absence in the dental literature of studies about the implications of temperature in the action of local anesthetics, the purpose of this preliminary study is to investigate the effects on the onset and the duration of pulpal anesthesia caused by lowering the temperature of the injected plain 3% mepivacaine from 20ЊC to 4ЊC.
METHODSTwenty healthy young volunteers (12 women and 8 men, age 21-23 years) who were students in the Dental School of Aristotle University of Thessaloniki were included in this study. Before agreeing to participate in the study, each subject signed a relevant consent that included a brief description of the purpose and the therapeutic procedures involved. All the experimental procedures were conducted in accordance with the protocols outlined by Aristotle University of Thessaloniki regarding the recommended standard practices for Biological Investigations.For each subject, 0.25 mL of 3% plain mepivacaine (Mepivastesin, 3M ESPE AG, ESPE Platz, D-82229 Seefeld, Germany) was slowly injected periapically with local infiltration in the maxillary first premolar (having no previous restorative treatment) in 2 appointments scheduled 1 week apart with the same tooth and by the same protocol. All injections were made with standard disposable 1-mL insulin syringes and 30-gauge needles. The quantity of 0.25 mL of mepivacaine was chosen after preliminary experiments as an appropriate dose because we did not want the total duration of the experiment to ...